Medicine guide

RIVASTIGMINE EG LABO

As listed in the register: RIVASTIGMINE EG LABO 9,5 mg/24 h, patch transdermique

13,8 mg · patch

  • Prescription only
Active substance
Rivastigmine
Made by
EG LABO - LABORATOIRES EUROGENERICS

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

BulgariaNo exact match for this strength and form

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byEG LABO - LABORATOIRES EUROGENERICS
Active substanceRivastigmine
Strength13,8 mg
Formpatch
Routetransdermique
Dispensing (as stated by the register)prescription réservée aux spécialistes et services NEUROLOGIE · médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services PSYCHIATRIE · prescription réservée aux spécialistes et services GERIATRIE · prescription réservée aux médecins spécialistes ou qualifiés en médecine générale titulaires de la capacité de gérontologie · prescription initiale annuelle réservée à certains spécialistes · liste I
MarketedYes, according to the register
Authorisation procedureProcédure de reconnaissance mutuelle
Name in the registerRIVASTIGMINE EG LABO 9,5 mg/24 h, patch transdermique
Packs30 sachet(s) papier polytéréphtalate (PET) aluminium polyacrylonitrile avec fermeture de sécurité enfant de 1 patch transdermique
CIS61430397
CIP133400930243015

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Other strengths and forms

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.